Literature DB >> 15807828

Novel ophthalmological features in hereditary endotheliopathy with retinopathy, nephropathy and stroke syndrome.

Amy C Cohn1, Katya Kotschet, Alistair Veitch, Martin B Delatycki, Mark F McCombe.   

Abstract

The ophthalmic features are reported of a member of an Australian pedigree with three affected individuals spanning two generations with a hereditary endotheliopathy syndrome resulting in retinopathy, leukoencephalopathy and nephropathy. The index case initially presented with asymptomatic retinopathy, cerebral microvascular disease, nephropathy and raised inflammatory markers. The clinical, neuro-radiological, biochemical and histopathological findings in this patient are consistent with a diagnosis of hereditary endotheliopathy, retinopathy, nephropathy and stroke (HERNS). Linkage analysis has identified a locus for HERNS on chromosome 3p21.1-p21.3. This locus is shared with two other diseases: hereditary vascular retinopathy (HVR) and cerebroretinal vasculopathy (CRV). Although peripheral retinal involvement is a feature of HVR, it has not previously been described in HERNS. This case represents a novel phenotype of HERNS, and serves to blur the distinction between the vasculopathies mapping to chromosome 3p21. Although previously thought to be distinct clinical entities, it is possible that HERNS, HVR and CRV simply represent different phenotypes of the same disease. This will only be clarified with the identification of the gene or genes. This case also raises the question of how best to manage rare forms of vascular retinopathy.

Entities:  

Mesh:

Year:  2005        PMID: 15807828     DOI: 10.1111/j.1442-9071.2005.00976.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

1.  A 44-year-old man with eye, kidney, and brain dysfunction.

Authors:  Ivana Vodopivec; Derek H Oakley; Cory A Perugino; Nagagopal Venna; E Tessa Hedley-Whyte; John H Stone
Journal:  Ann Neurol       Date:  2016-03-07       Impact factor: 10.422

2.  Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.

Authors:  Anine H Stam; Parul H Kothari; Aisha Shaikh; Andreas Gschwendter; Joanna C Jen; Suzanne Hodgkinson; Todd A Hardy; Michael Hayes; Peter A Kempster; Katya E Kotschet; Ingeborg M Bajema; Sjoerd G van Duinen; Marion L C Maat-Schieman; Paulus T V M de Jong; Marc D de Smet; Didi de Wolff-Rouendaal; Greet Dijkman; Nadine Pelzer; Grant R Kolar; Robert E Schmidt; JoAnne Lacey; Daniel Joseph; David R Fintak; M Gilbert Grand; Elizabeth M Brunt; Helen Liapis; Rula A Hajj-Ali; Mark C Kruit; Mark A van Buchem; Martin Dichgans; Rune R Frants; Arn M J M van den Maagdenberg; Joost Haan; Robert W Baloh; John P Atkinson; Gisela M Terwindt; Michel D Ferrari
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

3.  Hereditary endotheliopathy with retinopathy and encephalopathy: pathological and genetic studies of a family.

Authors:  Yu-Hua Fan; Jian Sun; Yun Yuan; Ling Chen; Zhong Pei; Shi-Hui Xing; Bing Liao; Jin-Sheng Zeng
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Renal histopathological findings of retinal vasculopathy with cerebral leukodystrophy.

Authors:  Yutaka Tsubata; Takashi Morita; Tetsuo Morioka; Taiji Sasagawa; Kouzo Ikarashi; Noriko Saito; Hisaki Shimada; Shigeru Miyazaki; Shinji Sakai; Hajime Tanaka; Rie Saito; Yasuko Toyoshima; Hiroaki Nozaki; Ichiei Narita
Journal:  CEN Case Rep       Date:  2018-01-10

Review 5.  New roles for the major human 3'-5' exonuclease TREX1 in human disease.

Authors:  David Kavanagh; Dirk Spitzer; Parul H Kothari; Aisha Shaikh; M Kathryn Liszewski; Anna Richards; John P Atkinson
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

Review 6.  Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline.

Authors:  Leif Østergaard; Thorbjørn S Engedal; Fiona Moreton; Mikkel B Hansen; Joanna M Wardlaw; Turgay Dalkara; Hugh S Markus; Keith W Muir
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.